Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Operating Margin (2018 - 2025)

AVITA Medical's Operating Margin history spans 8 years, with the latest figure at 23.83% for Q4 2025.

  • For Q4 2025, Operating Margin fell 15904.0% year-over-year to 23.83%; the TTM value through Dec 2025 reached 7.01%, up 1319.0%, while the annual FY2025 figure was 14.25%, 595.0% up from the prior year.
  • Operating Margin reached 23.83% in Q4 2025 per RCEL's latest filing, up from 54.17% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 182.88% in Q4 2024 to a low of 154.95% in Q1 2024.
  • Average Operating Margin over 5 years is 48.58%, with a median of 68.2% recorded in 2023.
  • Peak YoY movement for Operating Margin: soared 32902bps in 2021, then tumbled -15904bps in 2025.
  • A 5-year view of Operating Margin shows it stood at 84.74% in 2021, then increased by 26bps to 62.49% in 2022, then surged by 359bps to 161.79% in 2023, then rose by 13bps to 182.88% in 2024, then crashed by -87bps to 23.83% in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Operating Margin are 23.83% (Q4 2025), 54.17% (Q3 2025), and 61.17% (Q2 2025).